Has Paul Bednarz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,643 in general payments to Paul Bednarz, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Bednarz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Bednarz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Bednarz, MD

Foot and Ankle Surgery · Waco, TXNPI 1760476337

Payments from drug & device makers

$8,643in general payments, 2019–2025

Across 78 payments — averaging $110.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$5K
Pylant Medical$2K
Stryker$1K
Amgen$92
Pacira Pharmaceuticals Incorporated$50
Smith+Nephew$46
plus $96 from 3 others

What the payments were for

Travel & lodging$2,76532%
Food & beverage$2,15825%
Education$3,72043%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	30	$5,260
Pylant Medical	14	$1,946
Stryker(2 entities)	22	$1,153
Amgen(2 entities)	4	$92
Pacira Pharmaceuticals Incorporated	2	$50
Smith+Nephew	2	$46
Bioventus LLC	2	$33
Orthofix Medical, Inc.	1	$32
Johnson & Johnson	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,643 in reported general payments places this provider in the 70th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$55,127

Medicare patients

136

Services billed

548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	57	$767
Diclofenac Sodium	30	$591
Celecoxib	17	$591
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	51	$500
Meloxicam	150	$484
Methocarbamol	66	$262
Prednisone	51	$174

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Waco

Richard PollakSan Antonio$6.1M
Joseph CaporussoMcAllen$6M
Mark DaltonAustin$4.1M
William McGarveyKaty$3.5M
Eugene CurryDallas$3.1M
Chad HowzeSan Antonio$2.4M
Graham HamiltonEdinburg$2.1M
Kevin VarnerHouston$1.1M
Paul KimDallas$972K
Mark RobsonAustin$957K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →